CV Sciences (CVSI) Non-Current Deffered Revenue (2017 - 2020)
CV Sciences' (CVSI) quarterly Non-Current Deffered Revenue came in at $1.5 million in Q4 2020, up 9.33% quarter-over-quarter from $1.3 million in Q4 2018.
CV Sciences (CVSI) Non-Current Deffered Revenue (2017 - 2020) Analysis & Trends
CV Sciences has disclosed Non-Current Deffered Revenue across 3 years of filings, most recently posting $1.5 million for Q4 2020.
- Non-Current Deffered Revenue for Q4 2020 came in at $1.5 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2020 was $1.5 million (changed N/A YoY), and the FY2020 annual result was $1.5 million, changed N/A from the prior year.
- Non-Current Deffered Revenue came in at $1.5 million for Q4 2020 at CV Sciences, up from $1.3 million in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $1.5 million in Q4 2020 to a low of $1.1 million in Q4 2017.
- The 3-year median for Non-Current Deffered Revenue is $1.3 million (2018), against an average of $1.3 million.
- Peak annual rise in Non-Current Deffered Revenue reached 24.44% in 2018, while the deepest fall reached 24.44% in 2018.
- CV Sciences' Non-Current Deffered Revenue stood at $1.1 million in 2017, then gained by 24.44% to $1.3 million in 2018, then climbed by 9.33% to $1.5 million in 2020.
- The last three Non-Current Deffered Revenue figures came in at $1.5 million (Q4 2020), $1.3 million (Q4 2018), and $1.1 million (Q4 2017), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | CV Sciences | - | - | 1.56 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 1.45 Mn |
| Dec 31, 2018 | 1.33 Mn |
| Dec 31, 2017 | 1.07 Mn |